Journal of the Korea Academia-Industrial cooperation Society (한국산학기술학회논문지)

The Korea Academia-Industrial cooperation Society (한국산학기술학회)
권호 표지
DOI QR코드

DOI QR Code

An Analysis on Risk Factors of Colon Polyps with Health Examination Examinees

건강검진 대상자에서 대장용종의 위험요인 분석

  • Park, Yoen-Hwa (Graduate School of Public Health Chungnam National University Daejeon) ;
  • Yu, Ji-Hyun (Korea Atomic Energy Research Institute) ;
  • Lee, Tae-Yong (Department of Preventive Medicine and public Health, College of Medicine Chungnam National University)
  • 박연화 (충남대학교 보건대학원) ;
  • 유지현 (한국원자력연구원) ;
  • 이태용 (충남대학교 의학전문대학원 예방의학교실)
  • Received : 2014.02.24
  • Accepted : 2014.03.06
  • Published : 2014.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study aimed to analyze the occurrence of colon polyps and also risk factors of colon polyps. Among health examination examinees, 508 people were included who underwent colonoscopy and abdominal ultrasonography at the same time. Physical measurements also performed such as height, weight, blood pressure, waist measurement and BMI. General characteristics including age, sex, smoking, drinking and exercise as a risk factors were checked. At the same time, we analyzed various blood tests and fasting blood sugar through blood-gathering. In the results, regarding risk factors of colon polyps, AST, ALT, TC, fatty liver, obesity and smoking were shown significantly high. As a dependent variable with colon polyps, the highest relation was fatty liver(3.4 times), and then T-C(2.3 times). Smoking factor showed 2.3 times higher relation than non-smokers.

본 연구는 대장 용종 발생의 위험인자를 파악하기 위해 종합검진 수검자 중 대장내시경 검사와 복부초음파검사를 동시에 시행 받은 508명을 대상으로 나이, 성별, 흡연, 음주, 운동의 일반적인 특성과 신장, 체중, 혈압, 허리둘레, 체질량 지수 등의 신체 계측을 하였으며, 동시에 채혈을 통한 공복 시 혈당과 여러 가지 혈액검사를 분석하였다. 그 결과 AST, ALT, 총콜레스테롤, 지방간, 비만도 및 흡연여부가 유의하게 높은 것으로 나타났으며 대장용종이 있는 대상자가 지방간과의 관련성이 3.4배로가 가장 높았고, 다음으로 총콜레스테롤 2.3배, 흡연자가 비흡연자에 비해 2.3배나 위험성이 높게 나타났다.

Keywords

References

  1. http://www.nso.go.kr/kosis
  2. Jackman RJ, Mayo CW. The adenoma-carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 93, pp. 327-330, 1951.
  3. Selby JV1, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med, 326, pp. 653-657, 1992. DOI: http://dx.doi.org/10.1056/NEJM199203053261001
  4. Libby M. Morimoto, Polly A. Newcomb, Cornelia M. Ulrich, Roberd M. Bostick, Cynthia J. Lais, and John D. Potter. Risk factors for hyper-plastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev, 11, pp. 1012-1018, 2002.
  5. Morita T1, Tabata S, Mineshita M, Mizoue T, Moore MA, Kono S. 'The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study.' Asian Pac J Cancer Prev, 6, pp. 485-489, 2005.
  6. Kim MC, Kim DH, Jeong TH, Risk Factors of Colorectal Polyps in Korean Adults. J Korean Acad Fam Med 2002;23:890-896
  7. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med, 122, pp. 327-334, 1995. DOI: http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00002
  8. Executive Summary of the Third Report of the National Cholesterol Education Program(NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, pp. 2486- 2496, 2001.
  9. WHO West Pacific Region. The Asia-Pacific perspective: refining obesity concentration in man, Diabetologia, 28, pp. 412-419, 1985. https://doi.org/10.1007/BF00280883
  10. WHO Western Pacific Region, The Asia-Pacific perspective : Redefining obesity and its Treatment. 2000.
  11. Choi Byang In. Ultrasound diagnosis of the abdoman. Ilchokak, 147, 2006.
  12. Holtzman EJ, Yaari S, Goldbourt cholesterol and of colorectal caner (Letter). N Eng J Med, 317, pp. 114, 1987. DOI: http://dx.doi.org/10.1056/NEJM198707093170211
  13. Törnberg SA, Holm LE, Carstensen JM, Eklund GA, Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Eng J Med, 315, pp. 1629-1633, 1986. DOI: http://dx.doi.org/10.1056/NEJM198612253152601
  14. ST Hwang, YK Cho, JH Park, HJ Kim, DI Park, CI Sohn, WK Jeon, BI Kim, KH Won, W Jin, Association between Non-alcoholic Fatty Liver and clonic adenomatous polyps. The Korean journal of gastroenterology, 5(3), pp. 562-567, 2010.
  15. Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, Park SS, Yang S, Son HJ, Rhee PL, Kim JJ, Rhee JC, Choi YH, Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev, 16, pp. 1543-1546, 2007. DOI: http://dx.doi.org/10.1158/1055-9965.EPI-07-0199
  16. Elizabeth T. Jacobs, Dennis J. Ahnen, Erin L. Ashbeck, John A. Baron, E. Robert Greenberg, Peter Lance, David A. Lieberman, Gail McKeown-Eyssen, Arthur Schatzkin, Patricia A. Thompson, and Maria Elena Martinez, Association between body mass index and colorectal nesoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol, 169, pp. 657-666, 2009. https://doi.org/10.1093/aje/kwn401
  17. Shinchi K, Kono S, Honjo S, Todoroki I, Sakurai Y, Imanishi K, Nishikawa H, Ogawa S, Katsurada M, Hirohata, Obesity and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res, 85, pp. 479-484, 1994. DOI: http://dx.doi.org/10.1111/j.1349-7006.1994.tb02383.x
  18. Chung YW, Han DS, Park YK, Son BK, Paik CH, Lee HL, Jeon YC, Sohn JH, Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis, 38, pp. 668-672, 2006. DOI: http://dx.doi.org/10.1016/j.dld.2006.05.014
  19. Kono S, Handa K, Hayabuchi H, Kiyohara C, Inoue H, Marugame T, Shinomiya S, Hamada H, Onuma K, Koga H, Obesity weight gain and risk factor of colon adenomas in Japanese men. Jpn J Cancer Res, 90, pp.805-809, 1999. DOI: http://dx.doi.org/10.1111/j.1349-7006.1999.tb00819.x
  20. Hae Jin Kim; Hyeong Jin Kim; Kwang Eun Lee, Dae Jung Kim, Soo Kyung Kim, Chul Woo Ahn, Sung-Kil Lim, Kyung Rae Kim, Hyun Chul Lee, Kap Bum Huh, Bong Soo Cha, Metabolic significance of non-alcoholic fatty liver disease in non-obese adults. The Korean Journal of Medicine, 63(5), pp. 488-495, 2002.
  21. Dietz AT, Newcomb PA, Marcus PM, Storer BE, The association of body size and large bowel cancer risk in Wisconsin(United States) women. Cancer Causes Control, 6, pp. 30-36, 1995. DOI: http://dx.doi.org/10.1007/BF00051678
  22. Assy N, Kaita K, Mmin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in patients. Digestive diseases and science, pp. 1929-1934, 2000. DOI: http://dx.doi.org/10.1023/A:1005661516165
  23. Lee HL1, Son BK, Lee OY, Jeon YC, Han DS, Sohn JH, Yoon BC, Choi HS, Hahm JS, Lee MH, Lee DH, Kee CS, Abdominal obesity, insulin resistance, and the risk of colonic adenoma. Korean J Gastroenterol, 49, pp. 147-151, 2007.
  24. WG Choi, SJ Kim, SJ Myung, SO Choi, JH Kim, SW Park, SJ Park, EJ Jang, JS Park, HW. Baik, ER Kim, BJ Kim, Choi WK, Kim SJ, Myung SJ, et al. Relationship between Non-alcoholic Fatty Liver Disease and colonic adenomatous polyps in Examiners of a Health Promotion Center, The Korean Journal of Medicine, 41(4), pp. 201-207, 2010.
  25. Graham S, Marshall J, Haughey B, James M, Mittelman A, Swanson M, Zielezny M, Byers T, Wilkinson G, West D, Dietary epidemiology of cancer of the colon in western New York. Am J Epidemiol, 128, pp. 490-503, 1988. https://doi.org/10.1093/oxfordjournals.aje.a114997
  26. Boutron-Ruault MC, Senesse P, Meance S, Belghiti C, Faivre J. Energy intake, body mass index, physical activity, and thecolorectal adenoma-carcinoma sequence. Nutr Cancer, 39, pp. 50-57, 2001. DOI: http://dx.doi.org/10.1207/S15327914nc391_7
  27. Chyou PH, Nomura AM, Stemmermann GN. A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer, 57, pp. 313-317, 1994. DOI: http://dx.doi.org/10.1002/ijc.2910570304
  28. Nuengruetal O. Worapat A, Samornmas K, Teeranut B, Surasak S, Predicting the occurrence of cancer associated colo-rectal polyp using a metabolic risk score. Molecular and clinical oncology, 2, pp. 124-128, 2014. https://doi.org/10.3892/mco.2013.204